Hematological Malignancies

EORTC/GELA/IIL H10 Study Accrual 2006 - 2011

N=1950 randomized

Favorable n=754

Unfavorable n=1196

N=25 did not start/ complete first 2 cycles ABVD or no PET scan

Std n=371

Exp n=376

Std n=583

Exp N=595

PET positive

n=54 14%

n=43 11%

n=138 23%

n=126 21%

N=361

Median FU 4.5 yrs

Raemaekers et at; ICML 2015